Analyzing Array Data Using Supervised Methods
- 1 May 2002
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 3 (3) , 403-415
- https://doi.org/10.1517/14622416.3.3.403
Abstract
Pharmacogenomics is the application of genomic technologies to drug discovery and development, as well as for the elucidation of the mechanisms of drug action on cells and organisms. DNA microarrays measure genome-wide gene expression patterns and are an important tool for pharmacogenomic applications, such as the identification of molecular targets for drugs, toxicological studies and molecular diagnostics. Genome-wide investigations generate vast amounts of data and there is a need for computational methods to manage and analyze this information. Recently, several supervised methods, in which other information is utilized together with gene expression data, have been used to characterize genes and samples. The choice of analysis methods will influence the results and their interpretation, therefore it is important to be familiar with each method, its scope and limitations. Here, methods with special reference to applications for pharmacogenomics are reviewed.Keywords
This publication has 44 references indexed in Scilit:
- Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression DataJournal of the American Statistical Association, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Comprehensive Analysis of Photoreceptor Gene Expression and the Identification of Candidate Retinal Disease GenesCell, 2001
- Computational analysis of microarray dataNature Reviews Genetics, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Tissue Classification with Gene Expression ProfilesJournal of Computational Biology, 2000
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapySeminars in Cancer Biology, 1999
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998